naltrexone and Disruptive, Impulse Control, and Conduct Disorders

naltrexone has been researched along with Disruptive, Impulse Control, and Conduct Disorders in 32 studies

Research

Studies (32)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (3.13)18.2507
2000's17 (53.13)29.6817
2010's13 (40.63)24.3611
2020's1 (3.13)2.80

Authors

AuthorsStudies
Hamzaoui, S; Kebir, O; Laqueille, X; Mouaffak, F1
Astrup, A; Christensen, R; Johansen, KGV; Lund, H; Pagsberg, AK; Tarp, S1
Jahn, I; Olbrich, S; Stengler, K1
Spada, MM1
Duda, JE; Hurtig, H; Minger, J; Papay, K; Siderowf, A; Stern, M; Weintraub, D; Xie, SX1
Galduróz, JC; Ramos, AC; Santos-Galduróz, RF1
Groves, M; Liang, JW; Shanker, VL1
Papay, K; Weintraub, D; Xie, SX1
Berendse, HW; Nelis, EA; van den Heuvel, OA1
Fontenelle, LF; Piquet-Pessôa, M1
Allen, AR; Balleine, B; Carter, A; Clark, L; Dowling, NA; Gainsbury, SM; Goudriaan, AE; Grant, J; Hall, W; Hayes, A; Hodgins, D; Lattimore, R; Livingstone, C; Lorenzetti, V; Lubman, D; Murawski, C; Parkes, L; Petry, N; Room, R; Singh, B; Thomas, A; Townshend, P; van Holst, R; Youssef, G; Yücel, M1
Gorelick, DA; Gottheil, E; Mannelli, P; Patkar, AA; Peindl, K; Wu, LT1
Blanco, C; Grant, JE; Hollander, E; Kim, SW; Potenza, MN1
Grant, JE; Kim, SW; Odlaug, BL1
Coleman, E; Grant, JE; Raymond, NC1
Carminati, GG; Deriaz, N; Orihuela-Flores, M1
Belkız Güngör, B; Çetinay Aydın, P; Gülseren, L1
Kozian, R; Otto, FG1
Grant, JE; Grosz, R1
Baker, B; Baldini-Rossi, N; Hollander, E; Pallanti, S; Sood, E1
Cunningham-Williams, R; Grant, JE; Hollander, E; Kallio, A; Nurminen, T; Potenza, MN; Smits, G1
Grant, JE1
Hutchison, KE; Kaplan, GB; MacKinnon, SV; Monti, PM; Rohsenow, DJ; Sirota, AD; Swift, RM1
Grant, JE; Hartman, BK; Kim, SW1
Kim, SW1
Buchalter, AJ; DeCaria, CM; Hollander, E1
Adson, DE; Grant, JE; Kim, SW; Shin, YC1
Grant, JE; Kim, SW5

Reviews

9 review(s) available for naltrexone and Disruptive, Impulse Control, and Conduct Disorders

ArticleYear
Harms associated with taking nalmefene for substance use and impulse control disorders: A systematic review and meta-analysis of randomised controlled trials.
    PloS one, 2017, Volume: 12, Issue:8

    Topics: Disruptive, Impulse Control, and Conduct Disorders; Humans; Naltrexone; Substance Withdrawal Syndrome; Substance-Related Disorders

2017
An overview of problematic internet use.
    Addictive behaviors, 2014, Volume: 39, Issue:1

    Topics: Antidepressive Agents, Second-Generation; Behavior, Addictive; Central Nervous System Stimulants; Citalopram; Cognitive Behavioral Therapy; Comorbidity; Disruptive, Impulse Control, and Conduct Disorders; Humans; Internet; Methylphenidate; Mood Disorders; Naltrexone; Narcotic Antagonists; Prevalence; Substance-Related Disorders

2014
[Hypersexuality and other impulse control disorders in Parkinson's disease].
    Nederlands tijdschrift voor geneeskunde, 2016, Volume: 160

    Topics: Aged; Antiparkinson Agents; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Parkinson Disease; Sexual Dysfunction, Physiological; Treatment Outcome

2016
Opioid antagonists in broadly defined behavioral addictions: a narrative review.
    Expert opinion on pharmacotherapy, 2016, Volume: 17, Issue:6

    Topics: Alcoholism; Bulimia; Compulsive Behavior; Disruptive, Impulse Control, and Conduct Disorders; Gambling; Humans; Naltrexone; Narcotic Antagonists; Obsessive-Compulsive Disorder; Randomized Controlled Trials as Topic; Trichotillomania

2016
Neuroscience in gambling policy and treatment: an interdisciplinary perspective.
    The lancet. Psychiatry, 2017, Volume: 4, Issue:6

    Topics: Administrative Personnel; Appetite Depressants; Decision Making; Diagnostic and Statistical Manual of Mental Disorders; Disruptive, Impulse Control, and Conduct Disorders; Gambling; Harm Reduction; Humans; Naloxone; Naltrexone; Narcotic Antagonists; Neurosciences; Public Health

2017
[Pharmacological treatment of kleptomania--review].
    Psychiatrische Praxis, 2003, Volume: 30, Issue:4

    Topics: Disruptive, Impulse Control, and Conduct Disorders; Humans; Naltrexone; Narcotic Antagonists; Selective Serotonin Reuptake Inhibitors; Treatment Outcome

2003
Pharmacological treatments of pathological gambling.
    Journal of gambling studies, 2005,Spring, Volume: 21, Issue:1

    Topics: Antidepressive Agents, Second-Generation; Behavior, Addictive; Bupropion; Comorbidity; Disruptive, Impulse Control, and Conduct Disorders; Dose-Response Relationship, Drug; Fluvoxamine; Gambling; Humans; Naltrexone; Outcome Assessment, Health Care; Paroxetine; Piperazines; Research Design; Selective Serotonin Reuptake Inhibitors; Substance-Related Disorders; Triazoles

2005
Understanding and treating kleptomania: new models and new treatments.
    The Israel journal of psychiatry and related sciences, 2006, Volume: 43, Issue:2

    Topics: Algorithms; Cognitive Behavioral Therapy; Combined Modality Therapy; Disruptive, Impulse Control, and Conduct Disorders; Humans; Naltrexone; Narcotic Antagonists; Obsessive-Compulsive Disorder; Recurrence

2006
Pathological gambling.
    The Psychiatric clinics of North America, 2000, Volume: 23, Issue:3

    Topics: Cognitive Behavioral Therapy; Comorbidity; Diagnosis, Differential; Disruptive, Impulse Control, and Conduct Disorders; Female; Gambling; Humans; Male; Mental Disorders; Naltrexone; Narcotic Antagonists; Residential Treatment; Selective Serotonin Reuptake Inhibitors; Self-Help Groups

2000

Trials

10 trial(s) available for naltrexone and Disruptive, Impulse Control, and Conduct Disorders

ArticleYear
Exposure and response prevention therapy augmented with naltrexone in kleptomania: a controlled case study using galvanic skin response for monitoring.
    Behavioural and cognitive psychotherapy, 2019, Volume: 47, Issue:5

    Topics: Aged; Disruptive, Impulse Control, and Conduct Disorders; Female; Galvanic Skin Response; Humans; Implosive Therapy; Naltrexone; Narcotic Antagonists; Treatment Outcome

2019
Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study.
    Neurology, 2014, Aug-26, Volume: 83, Issue:9

    Topics: Aged; Disruptive, Impulse Control, and Conduct Disorders; Double-Blind Method; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Parkinson Disease

2014
Very low dose naltrexone addition in opioid detoxification: a randomized, controlled trial.
    Addiction biology, 2009, Volume: 14, Issue:2

    Topics: Adult; Analgesics, Opioid; Community Mental Health Services; Disruptive, Impulse Control, and Conduct Disorders; Double-Blind Method; Drug Administration Schedule; Female; Humans; Inactivation, Metabolic; Male; Methadone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Program Development; Substance Withdrawal Syndrome

2009
The Gambling Symptom Assessment Scale (G-SAS): a reliability and validity study.
    Psychiatry research, 2009, Mar-31, Volume: 166, Issue:1

    Topics: Disruptive, Impulse Control, and Conduct Disorders; Follow-Up Studies; Gambling; Humans; Naltrexone; Narcotic Antagonists; Obsessive-Compulsive Disorder; Personality Inventory; Psychometrics; Reproducibility of Results

2009
A double-blind, placebo-controlled study of the opiate antagonist, naltrexone, in the treatment of kleptomania.
    Biological psychiatry, 2009, Apr-01, Volume: 65, Issue:7

    Topics: Adolescent; Adult; Disruptive, Impulse Control, and Conduct Disorders; Double-Blind Method; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Placebos; Severity of Illness Index; Theft

2009
Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling.
    The American journal of psychiatry, 2006, Volume: 163, Issue:2

    Topics: Adult; Age of Onset; Ambulatory Care; Behavior, Addictive; Disruptive, Impulse Control, and Conduct Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drugs, Investigational; Female; Gambling; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Obsessive-Compulsive Disorder; Placebos; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome

2006
High-dose transdermal nicotine and naltrexone: effects on nicotine withdrawal, urges, smoking, and effects of smoking.
    Experimental and clinical psychopharmacology, 2007, Volume: 15, Issue:1

    Topics: Administration, Cutaneous; Administration, Oral; Adult; Blood Pressure; Breath Tests; Capsules; Carbon Monoxide; Demography; Disruptive, Impulse Control, and Conduct Disorders; Dose-Response Relationship, Drug; Female; Heart Rate; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Nicotine; Nicotinic Agonists; Smoking; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tablets

2007
A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges.
    The Journal of clinical psychiatry, 2008, Volume: 69, Issue:5

    Topics: Adolescent; Adult; Aged; Diagnostic and Statistical Manual of Mental Disorders; Disruptive, Impulse Control, and Conduct Disorders; Double-Blind Method; Drug Administration Schedule; Female; Gambling; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists

2008
Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling.
    Biological psychiatry, 2001, Jun-01, Volume: 49, Issue:11

    Topics: Adolescent; Adult; Aged; Disruptive, Impulse Control, and Conduct Disorders; Double-Blind Method; Gambling; Humans; Interview, Psychological; Liver Function Tests; Middle Aged; Naltrexone; Narcotic Antagonists; Single-Blind Method; Surveys and Questionnaires

2001
An open-label study of naltrexone in the treatment of kleptomania.
    The Journal of clinical psychiatry, 2002, Volume: 63, Issue:4

    Topics: Adult; Ambulatory Care; Disruptive, Impulse Control, and Conduct Disorders; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Placebos; Psychiatric Status Rating Scales; Reproducibility of Results; Severity of Illness Index; Sex Factors; Single-Blind Method; Treatment Outcome

2002

Other Studies

13 other study(ies) available for naltrexone and Disruptive, Impulse Control, and Conduct Disorders

ArticleYear
Kleptomania treated with naltrexone in a patient with intellectual disability
    Journal of psychiatry & neuroscience : JPN, 2020, 01-01, Volume: 45, Issue:1

    Topics: Adult; Disruptive, Impulse Control, and Conduct Disorders; Female; Humans; Intellectual Disability; Naltrexone; Narcotic Antagonists

2020
Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study.
    Neurology, 2015, Mar-31, Volume: 84, Issue:13

    Topics: Disruptive, Impulse Control, and Conduct Disorders; Female; Humans; Male; Naltrexone; Narcotic Antagonists; Parkinson Disease

2015
Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study.
    Neurology, 2015, Mar-31, Volume: 84, Issue:13

    Topics: Disruptive, Impulse Control, and Conduct Disorders; Female; Humans; Male; Naltrexone; Narcotic Antagonists; Parkinson Disease

2015
Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study.
    Neurology, 2015, Mar-31, Volume: 84, Issue:13

    Topics: Disruptive, Impulse Control, and Conduct Disorders; Female; Humans; Male; Naltrexone; Narcotic Antagonists; Parkinson Disease

2015
Augmentation with naltrexone to treat compulsive sexual behavior: a case series.
    Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 2010, Volume: 22, Issue:1

    Topics: Adult; Comorbidity; Compulsive Behavior; Disruptive, Impulse Control, and Conduct Disorders; Humans; Liver Function Tests; Male; Mental Disorders; Middle Aged; Minnesota; Naltrexone; Narcotic Antagonists; Retrospective Studies; Sexual Behavior; Sexual Dysfunctions, Psychological; Treatment Outcome

2010
Naltrexone in adults with intellectual disability improves compulsive and dissocial disorders: a case report.
    Progress in neuro-psychopharmacology & biological psychiatry, 2010, Aug-16, Volume: 34, Issue:6

    Topics: Adult; Compulsive Behavior; Disruptive, Impulse Control, and Conduct Disorders; Female; Humans; Intellectual Disability; Naltrexone; Narcotic Antagonists; Treatment Outcome

2010
Naltrexone treatment of kleptomania: a case report.
    Turk psikiyatri dergisi = Turkish journal of psychiatry, 2012,Winter, Volume: 23, Issue:4

    Topics: Antidepressive Agents, Second-Generation; Cognitive Behavioral Therapy; Depressive Disorder; Diagnosis, Differential; Disruptive, Impulse Control, and Conduct Disorders; Female; Fluoxetine; Humans; Naltrexone; Obsessive-Compulsive Disorder

2012
Pharmacotherapy outcome in older pathological gamblers: a preliminary investigation.
    Journal of geriatric psychiatry and neurology, 2004, Volume: 17, Issue:1

    Topics: Aged; Antidepressive Agents; Antimanic Agents; Bipolar Disorder; Comorbidity; Depressive Disorder, Major; Disruptive, Impulse Control, and Conduct Disorders; Drug Therapy, Combination; Female; Follow-Up Studies; Gambling; Humans; Male; Middle Aged; Naltrexone; Personality Assessment; Phobic Disorders; Psychotropic Drugs; Selective Serotonin Reuptake Inhibitors; Treatment Outcome

2004
Opioid antagonists in the treatment of impulse-control disorders.
    The Journal of clinical psychiatry, 1998, Volume: 59, Issue:4

    Topics: Adult; Compulsive Behavior; Disruptive, Impulse Control, and Conduct Disorders; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gambling; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists

1998
An open naltrexone treatment study in pathological gambling disorder.
    International clinical psychopharmacology, 2001, Volume: 16, Issue:5

    Topics: Adolescent; Adult; Aged; Disruptive, Impulse Control, and Conduct Disorders; Dose-Response Relationship, Drug; Female; Gambling; Humans; Male; Middle Aged; Motivation; Naltrexone; Personality Assessment; Psychiatric Status Rating Scales; Treatment Outcome

2001
Demographic and clinical features of 131 adult pathological gamblers.
    The Journal of clinical psychiatry, 2001, Volume: 62, Issue:12

    Topics: Adult; Aged; Disruptive, Impulse Control, and Conduct Disorders; Double-Blind Method; Female; Gambling; Humans; Male; Middle Aged; Motivation; Naltrexone; Paroxetine; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Socioeconomic Factors

2001
A case of kleptomania and compulsive sexual behavior treated with naltrexone.
    Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 2001, Volume: 13, Issue:4

    Topics: Compulsive Behavior; Disruptive, Impulse Control, and Conduct Disorders; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Sexual Behavior; Treatment Outcome

2001
Adolescent kleptomania treated with naltrexone--a case report.
    European child & adolescent psychiatry, 2002, Volume: 11, Issue:2

    Topics: Adolescent; Disruptive, Impulse Control, and Conduct Disorders; Female; Humans; Naltrexone; Narcotic Antagonists; Time Factors; Treatment Outcome

2002